Article ; Online: The Effect of Intermittent Preventive Treatment of Malaria During Pregnancy and Placental Malaria on Infant Risk of Malaria.
The Journal of infectious diseases
2021 Volume 225, Issue 2, Page(s) 248–256
Abstract: Background: Intermittent preventive treatment of malaria during pregnancy (IPTp) with dihydroartemisinin-piperaquine (DP) provides greater protection from placental malaria than sulfadoxine-pyrimethamine (SP). Some studies suggest placental malaria ... ...
Abstract | Background: Intermittent preventive treatment of malaria during pregnancy (IPTp) with dihydroartemisinin-piperaquine (DP) provides greater protection from placental malaria than sulfadoxine-pyrimethamine (SP). Some studies suggest placental malaria alters risk of malaria infection in infants, but few have quantified the effect of IPTp on infant susceptibility to malaria. Methods: Infants born to women enrolled in a randomized clinical trial comparing IPTp-SP and IPTp-DP in Malawi were followed from birth to 24 months to assess effect of IPTp and placental malaria on time to first malaria episode and Plasmodium falciparum incidence. Results: In total, 192 infants born to mothers randomized to IPTp-SP and 195 randomized to IPTp-DP were enrolled. Infants in IPTp exposure groups did not differ significantly regarding incidence of clinical malaria (incidence rate ratio [IRR], 1.03; 95% confidence interval [CI], .58-1.86) or incidence of infection (IRR, 1.18; 95% CI, .92-1.55). Placental malaria exposure was not associated with incidence of clinical malaria (IRR, 1.03; 95% CI, .66-1.59) or infection (IRR, 1.15; 95% CI, .88-1.50). Infant sex, season of birth, and maternal gravidity did not confound results. Conclusions: We did not find evidence that IPTp regimen or placental malaria exposure influenced risk of malaria during infancy in this population. Clinical Trials Registration. NCT03009526. |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
MeSH term(s) | Adult ; Antimalarials/therapeutic use ; Artemisinins/therapeutic use ; Drug Combinations ; Female ; Humans ; Infant ; Malaria/drug therapy ; Malaria/epidemiology ; Malaria/prevention & control ; Malawi/epidemiology ; Parasitemia/prevention & control ; Piperazines/therapeutic use ; Placenta/parasitology ; Pregnancy ; Pregnancy Complications, Parasitic/drug therapy ; Pregnancy Complications, Parasitic/epidemiology ; Pregnancy Complications, Parasitic/prevention & control ; Pyrimethamine/therapeutic use ; Quinolines/therapeutic use ; Sulfadoxine/therapeutic use ; Treatment Outcome | ||||||||||
Chemical Substances | Antimalarials ; Artemisinins ; Drug Combinations ; Piperazines ; Quinolines ; fanasil, pyrimethamine drug combination (37338-39-9) ; artenimol (6A9O50735X) ; Sulfadoxine (88463U4SM5) ; piperaquine (A0HV2Q956Y) ; Pyrimethamine (Z3614QOX8W) | ||||||||||
Language | English | ||||||||||
Publishing date | 2021-07-03 | ||||||||||
Publishing country | United States | ||||||||||
Document type | Journal Article ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural | ||||||||||
ZDB-ID | 3019-3 | ||||||||||
ISSN | 1537-6613 ; 0022-1899 | ||||||||||
ISSN (online) | 1537-6613 | ||||||||||
ISSN | 0022-1899 | ||||||||||
DOI | 10.1093/infdis/jiab351 | ||||||||||
Shelf mark |
|
||||||||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uh II Zs.50: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 445: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.